Progressive Care Inc (RXMD)

[angeloh]

Yep, will be looking for the 8's by Friday...
Riding the Green Wave up with you my friends...

$RXMD = GREAT INVESTMENT, OVER 20 MILLION REVS
RXMD IS ON A COURSE FOR SUCCESS, ON OTCQB and NASDAQ
OUTLOOK FOR 2018: Completion of TWO REVENUE PRODUCING ACQUISTIONS (TouchPointRX Complete)
OUTLOOK FOR 2019: SEC Reporting Compliance, NASDAQ Uplist, and more ACQUISITIONS
ALL POINTS TO CONTINUED DEVELOPMENT AND GROWTH THROUGH EXPANSION ****INVEST WISELY****

WITH EXTREMELY LOW SHARE STRUCTURE
RXMD Security Details
Share Structure
Authorized Shares
500,000,000 08/31/2018
Outstanding Shares
431,221,376 on 08/31/2018 This balance also includes 5,590,432 common shares that were beneficially owned by Progressive Care through PharmCo, LLC and Progressive Training, Inc. and will be retired back to Treasury. So actual amount is 425,630,944 Outstanding on F/S
Previously 428,997,097 on 7/17/18
Restricted
82,224,982 08/31/2018
Unrestricted
348,996,394 08/31/2018
Float
334,506,590 03/31/2018

SHORT TERM PRICE TARGET $.35
https://finance.yahoo.com/news/seethruequity-issues-progressive-care-inc-131500911.html
http://www.seethruequity.com/wp-content/uploads/2018/03/RXMD-UPDATE-MAR-9-2018-FINAL.pdf
[/color]

***THE REAL DEAL***
TWO REAL BRICK AND MORTAR LOCATIONS SERVICING:
MIAMI DADE COUNTY, FLORIDA
MARTIN COUNTY, FLORIDA
PALM BEACH COUNTY, FLORIDA
BROWARD COUNTY, FLORIDA
ST. LUCIE COUNTY, FLORIDA
70 Employees
2 YEARS AUDITED FINANCIAL STATEMENTS
OTCQB with INDEPENDENT BOARD and AUDIT COMMITTEE MEMBERS

HERES SOME JUICY 2018 NUMBERS - W NEW LOCATION ACQUIRED 3/30/18, these revenues will start to be recognized July 1, 2018
Scripts: 187,877 a 8.7% increase compared to August 31, 2017
Net Revenue: $14.1 million, a $565,000+ increase compared to August 31, 2017
340B Sales: $3.8 million, a $2.2 million+ increase compared to August 31, 2017
Annualized, 2018 340B Sales are estimated at $6.1 Million, that's a 120% increase over 2017's $2.75 Million. PharmCoRX is obviously increasing the number of customers.